Email this page
Print
Bookmark and share
Bigger
Smaller
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Articles on antidepressants from NPS RADARArticles on antidepressants from NPS RADAR
| Title | Content Type | Date | Description |
|---|---|---|---|
| Desvenlafaxine (Pristiq) for major depressive disorder | Professional publication - NPS RADAR - Review | 2009-03-10 00:00:00 | Theoretically, desvenlafaxine has lower potential for drug interactions than its parent drug venlafaxine, but this does not appear to confer any particular clinical advantage. |
| Duloxetine (Cymbalta) for major depressive disorder | Professional publication - NPS RADAR - Review | 2008-08-01 00:00:00 | Duloxetine is a serotonin and noradrenaline reuptake inhibitor (SNRI) antidepressant, in the same class as venlafaxine. It provides another treatment option, but does not offer any particular advantages over existing therapies. |
| Escitalopram (Lexapro, Esipram) for generalised anxiety disorder and social anxiety disorder (social phobia) | Professional publication - NPS RADAR - Review | 2008-08-01 00:00:00 | Escitalopram is the first selective serotonin re-uptake inhibitor (SSRI) to be PBS listed for these indications. The listing does not cover mild anxiety states for which other forms of treatment are more appropriate. Patients are eligible for escitalopram on the PBS if they fail non-pharmacological therapies and have a GP Mental Health Care Plan, or have been assessed by a psychiatrist. |
| Selective serotonin re-uptake inhibitors in child and adolescent depression | Professional publication - NPS RADAR - Review | 2005-04-01 00:00:00 | Reviews evidence-based guidelines for use of SSRI antidepressants in children and adolescents and warns of increased risk of suicidality. |
| Sertraline, fluoxetine for premenstrual dysphoric disorder | Professional publication - NPS RADAR - Review | 2004-12-01 00:00:00 | Reviews use of sertraline (Zoloft) and fluoxetine (Lovan, Prozac) for premenstrual dysphoric disorder, including diagnosis criteria and combination with behavioural therapy. |
| Escitalopram (Lexapro) for major depressive disorder | Professional publication - NPS RADAR - Review | 2004-02-01 00:00:00 | Reviews use of escitalopram for major depressive disorder, including comparison with citalopram and isomer drug design. |
View all RADAR articles by date, by therapeutic topic, or by active ingredient, or find out more about NPS RADAR.
NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.
Date published: 2009-10-28 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
